(Total Views: 598)
Posted On: 02/28/2022 4:51:25 PM
Post# of 155776
Quote:
CytoDyn will keep shareholders and stakeholders informed on the Company’s progress in implementing its leadership transition plan as and when appropriate.
Now might me the time to give us a damn clue. We went from a:
"webcast to discuss and provide updates with regard to NASH data results (350 and 700 mg), Cancer, COVID-19, HIV BLA, and finances of the Company on Thursday, January 13, 2022"
to absolutely no idea what the hell is going on, so CytoDyn, I feel you have a fiduciary obligation to give those of us who support you a PR.
(5)
(0)
